A Phase Ⅲ Clinical Study of MIL62 in Primary Membranous Nephropathy
A Phase Ⅲ Clinical Study of MIL62 in Primary Membranous Nephropathy
Active, not recruiting · NCT05862233 · Registry updated 2025-08-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase Ⅲ Clinical Study of MIL62 in Primary Membranous Nephropathy | Primary Membranous Nephropathy | Active, not recruiting | Phase 3 | 2025-08-20 | NCT05862233 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Beijing Mabworks Biotech Co., Ltd. | 11 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking University First Hospital | Beijing | China | 72 |